NM_002471.4:c.411G>A

Variant summary

Our verdict is Benign. The variant received -19 ACMG points: 0P and 19B. BP4_ModerateBP6_Very_StrongBP7BA1

The NM_002471.4(MYH6):​c.411G>A​(p.Glu137Glu) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.24 in 1,614,008 control chromosomes in the GnomAD database, including 48,836 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.22 ( 3915 hom., cov: 32)
Exomes 𝑓: 0.24 ( 44921 hom. )

Consequence

MYH6
NM_002471.4 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:11

Conservation

PhyloP100: 0.342

Publications

19 publications found
Variant links:
Genes affected
MYH6 (HGNC:7576): (myosin heavy chain 6) Cardiac muscle myosin is a hexamer consisting of two heavy chain subunits, two light chain subunits, and two regulatory subunits. This gene encodes the alpha heavy chain subunit of cardiac myosin. The gene is located approximately 4kb downstream of the gene encoding the beta heavy chain subunit of cardiac myosin. Mutations in this gene cause familial hypertrophic cardiomyopathy and atrial septal defect 3. [provided by RefSeq, Feb 2017]
MYH6 Gene-Disease associations (from GenCC):
  • hypertrophic cardiomyopathy 14
    Inheritance: AD Classification: STRONG, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), PanelApp Australia, Laboratory for Molecular Medicine
  • Keppen-Lubinsky syndrome
    Inheritance: AD Classification: MODERATE Submitted by: Illumina
  • familial isolated dilated cardiomyopathy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • atrial septal defect 3
    Inheritance: AD Classification: LIMITED Submitted by: G2P
  • dilated cardiomyopathy
    Inheritance: AD Classification: LIMITED Submitted by: ClinGen
  • hypertrophic cardiomyopathy
    Inheritance: AD Classification: LIMITED Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -19 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.41).
BP6
Variant 14-23405314-C-T is Benign according to our data. Variant chr14-23405314-C-T is described in ClinVar as Benign. ClinVar VariationId is 44504.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=0.342 with no splicing effect.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.258 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_002471.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
MYH6
NM_002471.4
MANE Select
c.411G>Ap.Glu137Glu
synonymous
Exon 5 of 39NP_002462.2

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
MYH6
ENST00000405093.9
TSL:5 MANE Select
c.411G>Ap.Glu137Glu
synonymous
Exon 5 of 39ENSP00000386041.3
MYH6
ENST00000557461.2
TSL:5
n.478G>A
non_coding_transcript_exon
Exon 5 of 14

Frequencies

GnomAD3 genomes
AF:
0.218
AC:
33077
AN:
152074
Hom.:
3916
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.170
Gnomad AMI
AF:
0.387
Gnomad AMR
AF:
0.195
Gnomad ASJ
AF:
0.299
Gnomad EAS
AF:
0.0561
Gnomad SAS
AF:
0.179
Gnomad FIN
AF:
0.210
Gnomad MID
AF:
0.228
Gnomad NFE
AF:
0.261
Gnomad OTH
AF:
0.224
GnomAD2 exomes
AF:
0.207
AC:
52054
AN:
251464
AF XY:
0.212
show subpopulations
Gnomad AFR exome
AF:
0.161
Gnomad AMR exome
AF:
0.125
Gnomad ASJ exome
AF:
0.300
Gnomad EAS exome
AF:
0.0561
Gnomad FIN exome
AF:
0.212
Gnomad NFE exome
AF:
0.258
Gnomad OTH exome
AF:
0.232
GnomAD4 exome
AF:
0.243
AC:
354887
AN:
1461816
Hom.:
44921
Cov.:
59
AF XY:
0.242
AC XY:
175697
AN XY:
727210
show subpopulations
African (AFR)
AF:
0.167
AC:
5590
AN:
33474
American (AMR)
AF:
0.133
AC:
5949
AN:
44720
Ashkenazi Jewish (ASJ)
AF:
0.297
AC:
7774
AN:
26136
East Asian (EAS)
AF:
0.0475
AC:
1887
AN:
39700
South Asian (SAS)
AF:
0.188
AC:
16210
AN:
86252
European-Finnish (FIN)
AF:
0.219
AC:
11694
AN:
53414
Middle Eastern (MID)
AF:
0.213
AC:
1229
AN:
5764
European-Non Finnish (NFE)
AF:
0.261
AC:
290331
AN:
1111970
Other (OTH)
AF:
0.236
AC:
14223
AN:
60386
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.480
Heterozygous variant carriers
0
19985
39970
59956
79941
99926
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
9626
19252
28878
38504
48130
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.217
AC:
33090
AN:
152192
Hom.:
3915
Cov.:
32
AF XY:
0.215
AC XY:
15962
AN XY:
74414
show subpopulations
African (AFR)
AF:
0.170
AC:
7054
AN:
41524
American (AMR)
AF:
0.194
AC:
2972
AN:
15292
Ashkenazi Jewish (ASJ)
AF:
0.299
AC:
1038
AN:
3472
East Asian (EAS)
AF:
0.0564
AC:
292
AN:
5178
South Asian (SAS)
AF:
0.179
AC:
861
AN:
4820
European-Finnish (FIN)
AF:
0.210
AC:
2225
AN:
10602
Middle Eastern (MID)
AF:
0.218
AC:
64
AN:
294
European-Non Finnish (NFE)
AF:
0.261
AC:
17764
AN:
67986
Other (OTH)
AF:
0.221
AC:
467
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
1347
2694
4041
5388
6735
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
350
700
1050
1400
1750
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.243
Hom.:
7436
Bravo
AF:
0.211
Asia WGS
AF:
0.122
AC:
423
AN:
3478
EpiCase
AF:
0.264
EpiControl
AF:
0.266

ClinVar

Significance: Benign
Submissions summary: Benign:11
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:7
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Sep 27, 2011
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

Clinical Genetics, Academic Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

Jun 10, 2013
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

not provided Benign:2
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

Mar 03, 2015
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Hypertrophic cardiomyopathy 14 Benign:1
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Cardiovascular phenotype Benign:1
Jun 16, 2015
Ambry Genetics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity.

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.41
CADD
Benign
7.0
DANN
Benign
0.55
PhyloP100
0.34
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2277474; hg19: chr14-23874523; COSMIC: COSV62453843; API